Zafgen Secures $20,000,000 New Financing

  • Feed Type
  • Date
  • Company Name
  • Mailing Address
    One Broadway 8th Floor Cambridge, MA 02142 USA
  • Company Description
    We are developing beloranib, a novel obesity therapy that demonstrates a unique mechanism of action, re-establishing balance to the ways the body produces and uses fat stored in adipose tissue.
  • Website
  • Transaction Type
  • Transaction Amount
  • Transaction Round
  • Proceeds Purposes
    Proceeds of the loan will be used for working capital growth.
  • M&A Terms
  • Venture Investor
  • Venture Investor

Trending on Xconomy